Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  20.584 10:14 AM EDT  
    Day High 21.07 09:32 AM EDT
    Range 0.49  
    Volume 258,780  
    30-Day Avg Vol 517,000
    Difference -49.95%  
    Market Cap 691.24 M  
    Mkt Cap Chg -15.28 M  
    Shares Out 33.23 M  
    % Shrs Traded 0.78%  
    1yr EPS Est 1.255  
    52-Wk Low 15.36 3/9/09
    52-Wk High 39.60 8/14/08
    Range 24.24  
    Prev Close 21.26 7/1/09  
    Today's Open 21.03  
    Change -1.08%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date
    Div Date
    Short Interest 4.59 M

    Performance Details

    Revenue (LFY) 352.36 M  
    Earnings (LFY) 37.67 M  
    Earnings (MRQ) 11.02 M  
    Next Earn Est 0.274  
    Next Earnings 12/11/2009
    EPS (TTM) 1.21  
    1yr EPS Growth 7.26%  
    P/E Ratio (TTM) 17.19  
    P/E Ratio (Fwd) 16.00  
    PEG Ratio 1.16  
    Return on Equity 6.59  
    Beta 0.97  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: MATK

    Blogs are not currently available for matk.

    View all blogs at BloggingStocks.

  • Related Information: MATK

    Company Overview: MATK

    Martek Biosciences' nutritional and pharmaceutical products promote the popularity of pond scum. The firm has developed nutritional oils from microalgae and fungi for use in baby formula (the oils provide ... View Full Description

    Earnings Analysis: MATK

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter 0.274 9/2/09
    Last Quarter 0.291 4/30/09 0.33 4/30/09 0.039
    Beat
    2 Quarters Ago 0.287 1/31/09 0.29 1/31/09 0.003
    Beat

    Financials: MATK

      Quarterly - 04/30/2009 Annual - 2008
    Total Revenue 92.41 M 352.36 M
    Gross Profit 35.72 M 138.09 M
    Operating Income 16.90 M 56.18 M
    Net Income 11.02 M 37.67 M